Exposure to high-priority drug-drug interactions among non-elderly adults in Quebec: a cohort study [Prescribing and pharmacotherapeutics]
Annals of Family Medicine
NOVEMBER 20, 2024
Harmful prescription drug-drug interactions (DDI) arise when the effects of one drug change the effect of another drug and increase the risk for an adverse event, including therapeutic failure. 2) to measure the association between exposure to 4 high-priority DDI and the risk of an adverse event. Results: 1) 11.7% (95% CI: 11.5-12.0)
130 
Let's personalize your content